Advertisement


Steven Shak, MD, on Breast Cancer–Specific Mortality

2016 Quality Care Symposium

Advertisement

Steven Shak, MD, of Genomic Health, discusses mortality among patients with early-stage hormone receptor–positive invasive breast cancer in the SEER database who were treated based on the 21-gene Recurrence Score results (Abstract 176).



Related Videos

Cost of Care

Sarina Isenberg, PhD Candidate, on Better Care at a Better Cost

Sarina Isenberg, PhD Candidate, of the Johns Hopkins Bloomberg School of Public Health, discusses the cost savings of a comprehensive hospital-based palliative care program. (Abstract 2)

Issues in Oncology

Kerin B. Adelson, MD, on Improving Cancer Staging

Kerin B. Adelson, MD, of the Yale Cancer Center, discusses an electronic decision support tool to capture staging data. This information allows automated reports for clinical trial screening, outcomes analysis, quality comparisons, and reporting. (Abstract 151)

Issues in Oncology

Joseph O. Jacobson, MD, on Improving Cancer Care: What Works, What Doesn’t, and Why

Joseph O. Jacobson, MD, of the Dana-Farber Cancer Institute, discusses a session he co-chaired on the thorny questions of how best to improve cancer care.

Issues in Oncology

Allison Kurian, MD, on Assessing Quality in the Age of Precision Medicine

Allison Kurian, MD, of Stanford University School of Medicine, discusses pressing questions about the clinical utility and value of extended genomic testing and other forms of precision medicine.

Issues in Oncology

Lee N. Newcomer, MD, on Assessing Quality: Payer Perspective

Lee N. Newcomer, MD, of the UnitedHealth Group, gives his perspective on how to assess quality in the age of precision medicine.

Advertisement

Advertisement



Advertisement